Research Evidence Comparison# BPC-157 Research# BPC-157 has extensive preclinical data but no published human trials: GI healing studies (animal models) : Gastric ulcer healing in rat models with multiple induction methods Inflammatory bowel disease models showing reduced inflammation and mucosal healing Esophagitis, duodenal ulcer, and fistula healing in rodents Liver protection in hepatotoxicity models Non-GI healing studies (animal models) : Tendon and ligament repair (Achilles tendon, MCL models) Muscle healing after crush injury Bone fracture healing Peripheral nerve regeneration Brain-gut axis modulation Evidence level : Low -- extensive preclinical data, no human clinical trials
B12 and Weight Loss: How a B12 Shot Can Support Weight Loss Vitamin B, in general, increases energy
Because thymosin beta-4 is involved in cellular migration, actin dynamics, angiogenesis, and wound-healing biology, public discussions often frame TB-500 as a systemic recovery-support peptide
Immunogenicity: No Antibody Formation A critical safety consideration for any peptide therapy is immunogenicity, the potential to trigger immune system responses that could lead to allergic reactions, reduced efficacy through antibody neutralization, or autoimmune complications
Category 2 designation means the substance presents "safety concerns" and is prohibited from being used in compounding by licensed pharmacies
Use a laminar flow hood where available